These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Arsenical encephalopathy during treatment of tropical eosinophilia. SINGH B Br Med J; 1948 Dec; 2(4589):1061. PubMed ID: 18121623 [No Abstract] [Full Text] [Related]
23. [The chemical signs of arsenical intoxication]. BRUSTIER V Maroc Med; 1952 Feb; 31(321):101-5. PubMed ID: 14947220 [No Abstract] [Full Text] [Related]
24. [Certain comments on arsenical polyneuritis]. BARRAQUER-FERRE L; CASTANER-VENDRELL E; RUIZ-LARA R Prensa Med Argent; 1952 Sep; 39(38):2230-7. PubMed ID: 12993709 [No Abstract] [Full Text] [Related]
25. Arsenic contents of human organs after fatal poisoning with arsenic trioxide and other arsenical compounds, with some remarks on the manifestations of arsenic poisoning. HANSE F; MØLLER KO Acta Pharmacol Toxicol (Copenh); 1949 Aug; 5(2):135-52. PubMed ID: 18143952 [No Abstract] [Full Text] [Related]
26. Toxic effects of arsenical compounds as employed in the treatment of diseases in the United States Navy, 1944. BURTON OL; JUSTYN GW; ANDERSON LT U S Nav Med Bull; 1946 Jan; 46():139-62. PubMed ID: 21009070 [No Abstract] [Full Text] [Related]
28. [Arsenical melanosis and silicosis in glass worker]. GILJE O Nord Med; 1951 Oct; 46(43):1606-8. PubMed ID: 14899759 [No Abstract] [Full Text] [Related]
29. Clinical uses of 2,3-dimercaptopropanol (BAL); the effect of BAL on the excretion of arsenic in arsenical intoxication. LUETSCHER JA; EAGLE H; LONG-COPE WT J Clin Invest; 1946 Jul; 25(4):534-40. PubMed ID: 21001627 [No Abstract] [Full Text] [Related]
31. Use of BAL in the treatment of arsenical neuropathy. MALHOTRA SL Ind Med Gaz; 1951 Aug; 86(8):340-3. PubMed ID: 14888288 [No Abstract] [Full Text] [Related]
32. [Deadly arsenical encephalopathy, late trial of B.A.L treatment]. PECKER A; SIGUIER F; PERIER R Ann Dermatol Syphiligr (Paris); 1947 Jun; 7(6):214. PubMed ID: 18900230 [No Abstract] [Full Text] [Related]
34. Arsenical keratoses disappearing with vitamin A therapy. HALL AF Arch Derm Syphilol; 1946 Feb; 53():154. PubMed ID: 21015847 [No Abstract] [Full Text] [Related]
35. Myocardial fibrosis following arsenical therapy. EDGE JR Lancet; 1946 Nov; 2(6428):675-7. PubMed ID: 21002494 [No Abstract] [Full Text] [Related]
36. Clinical uses of 2,3-dimercaptropropanol (BAL); the effect of BAL on the excretion of arsenic in normal subjects and after minimal exposure to arsenical smoke. WEXLER J; EAGLE H J Clin Invest; 1946 Jul; 25(4):467-73. PubMed ID: 21001621 [No Abstract] [Full Text] [Related]
37. Toxic effects of arsenical compounds as employed in the treatment of syphilis in the United States Navy 1945. BURTON OL; JUSTYN GW; ANDERSON LT U S Nav Med Bull; 1947; 47(1):180-97. PubMed ID: 20284337 [No Abstract] [Full Text] [Related]
38. Occupational arsenical dermatitis; a study among employees at a copper ore smelting work including investigations of skin reactions to contact with arsenic compounds. HOLMQVIST I Acta Derm Venereol Suppl (Stockh); 1951; 26():1-214. PubMed ID: 14868348 [No Abstract] [Full Text] [Related]
39. [Anatomo-clinical case of arsenical encephalopathy]. DE MORSIER G; FELDMANN H Encephale; 1951; 40(2):97-107. PubMed ID: 13068314 [No Abstract] [Full Text] [Related]
40. [Differential diagnosis between the eclamptic seizures and convulsions produced by arsenical encephalopathy in pregnant women]. DE GODOY CM Rev Paul Med; 1949 Apr; 34(4):257-62. PubMed ID: 18127947 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]